UnitedHealth Group Shows Signs of Recovery

UnitedHealth Group, a major conglomerate, appears to be bouncing back from a significant profit drop last year. The company announced its first-quarter profits on Tuesday, exceeding Wall Street’s forecasts.

Despite this positive news, revenue remained largely unchanged year-over-year. This reflects the ongoing struggles UnitedHealth faces, including rising medical costs, scrutiny from the government on its billing practices, and an ongoing public distrust of health insurance companies. As the first major commercial insurer to release its financial results for the first quarter of 2026, UnitedHealth’s performance highlights that industry-wide challenges persist.

Net income stood at $6.48 billion, translating to $6.90 per share, which is a slight increase from $6.47 billion, or $6.85 per share, during the same period last year. First-quarter sales rose to $111.7 billion, up from $109.6 billion.

Wayne DeVate, the company’s chief financial officer, stated, “Our first quarter results reflect improved fundamentals and operational strength across our business.” He underscored enhancements in the medical expense ratio, which gauges how much of the company’s premiums go towards medical expenses. UnitedHealth managed to raise prices while controlling costs to improve these ratios.

Outlook and Analyst Reactions

UnitedHealth has upped its earnings outlook for 2026, projecting adjusted earnings per share to exceed $18.25. Analysts viewed this report as a constructive sign of progress. Brian Mulberry from Zacks Investment Management noted that the overall profitability is on the rise, and suggested that restructuring and investments in artificial intelligence may yield even better results.

Following the report, shares jumped nearly 9%, trading around $352.86 by mid-morning Tuesday. Notably, the stock had peaked at over $600 per share in November 2024.

Once considered one of the most respected companies in the U.S., UnitedHealth’s performance suffered dramatically last spring, with its stock price almost halving in just a few months.

Leadership Changes and Strategies

The company unexpectedly replaced its CEO, reinstating Stephen Hemsley, with intentions to revitalize the business and return to double-digit growth.

UnitedHealth has long succeeded by diversifying its healthcare offerings, from being the largest health insurer in the nation to managing extensive data operations, medical practices, and pharmacy benefit services.

The company operates UnitedHealthcare, an insurance provider that serves 49 million individuals and is among the largest distributors of Medicare Advantage plans. Through Optum, it offers care via a vast network of around 90,000 affiliated physicians, and its pharmacy benefit manager, Optum Rx, processes prescriptions for about 60 million patients.

Additionally, the conglomerate owns Change Healthcare, which handles a significant portion of U.S. claims between pharmacies, hospitals, and insurance providers. Unfortunately, this entity was also the victim of a severe cyberattack in 2024.

Concerns about its vast influence in the healthcare sector prompted some lawmakers to push for the company’s breakup.

Ongoing Challenges and Market Dynamics

As of last spring, UnitedHealth’s expansion has largely come to a standstill, shifting focus to cost-cutting measures, including retreating from some operations outside the U.S. and UK, and reevaluating its executive team. Hemsley noted these strategies when discussing the first-quarter results: “We continue to help simplify and modernize healthcare for the people we serve, delivering greater value, affordability, transparency, and connectivity.”

The company is also heavily investing in AI, planning to allocate about $1.5 billion this year. “We’re leaning into this,” Hemsley remarked during a recent analyst call.

UnitedHealth aims to leverage this technology to streamline medical approvals, enhancing the overall customer experience. A new bot named Avery, designed to assist individuals in navigating their health benefits, was introduced last month.

However, the company’s Medicare Advantage business has faced its own challenges. Federal authorities are increasingly scrutinizing the program, citing concerns over inflated diagnoses and potential overbilling to the government, which remain under oversight.

The market conditions are growing less favorable for UnitedHealth, as a rise in the sickness among the insured and escalating medical costs have taken a toll. The company has reported a loss of nearly 1 million customers in the Medicare Advantage sector.

UnitedHealth also anticipates a revenue decrease of about $6 billion this year due to changes in how Medicare Advantage services are compensated, though the recent government decision to increase total payouts next year may offer some relief.

Similar to other major insurers in the nation, UnitedHealth has faced criticism from the public and lawmakers for practices such as pre-authorizing certain services, which can delay necessary treatments. The company plans to simplify these approval processes, aiming to cut the number of medical approvals by at least 30% by year-end.

With healthcare costs—especially premiums and out-of-pocket expenses—top-of-mind for many as midterm elections approach, public sentiment remains fraught. The tragic murder of the company’s head of health insurance, Brian Thompson, in late 2024 only intensified existing frustrations toward insurers.

Across the board, lawmakers from both parties have often blamed corporations for escalating healthcare costs, an issue that consistently ranks high on constituents’ minds.